Buy Retatrutide Value Pack 3 x 10mg in Australia
Buy the Retatrutide value pack in Australia from Macropus Peptides: three sealed 10mg vials of research-grade lyophilised peptide, all drawn from one lot. Each vial carries its own printed label with compound, strength, lot number and storage temperature, and the certificate of analysis for that lot is sent on request. Splitting 30 milligrams across three small vials lets a laboratory reconstitute one at a time while the other two stay dry and sealed in the freezer. The pack costs slightly less per vial than buying three single Retatrutide 10mg vials, so repeat buyers of the small strength save a little on every order. Bacteriostatic water is sold separately and can join the same cart. Parcels leave our Australian premises for every state and territory. Sold to buyers aged 18 and over for in-vitro laboratory research only, never for human or animal use.
| Kit | Retatrutide value pack 3 × 10mg |
|---|---|
| Amount | 3 × 10 mg |
| Form | Research kit |
| Contents | Three Retatrutide 10mg vials |
| Category | Kits, stacks and value packs |
| Storage | See label |
| Testing | HPLC purity and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
Buy Retatrutide Value Pack Australia: 3 x 10mg Vials
Macropus Peptides packs three Retatrutide 10mg vials together as a single order line. The vials are filled from the same lot, sealed individually and labelled individually, so the pack behaves like three separate small vials that happen to share one batch record. It is aimed at laboratories that already know the 10mg size suits their bench routine and want a reserve on hand without mixing lots.
What is in the Retatrutide 3 x 10mg pack
- Three glass vials, each holding 10 milligrams of lyophilised Retatrutide
- A crimped cap and rubber septum on every vial
- Its own printed label: compound, strength, lot, storage
- One shared lot number, with its certificate of analysis available when you ask
No diluent or syringes are included; those are chosen separately so the order matches your protocol.
Retatrutide in brief: a triple receptor research peptide
The compound is a synthetic peptide engineered to activate three receptors at once: those for GLP-1, GIP and glucagon. Most metabolic research tools touch only one or two of these, so it gives scientists a way to ask what the glucagon arm contributes on top of the incretin pair. Attached to the backbone is a fatty acid chain that grips circulating albumin, stretching out how long the molecule lingers. Cell Metabolism carried the discovery paper in 2022; phase 2 reports then appeared in NEJM and The Lancet. For mechanism detail and every catalogued study, see the main Retatrutide vial page and the Retatrutide research studies library.
Retatrutide value pack specifications
| Specification | Detail |
|---|---|
| Kit | Retatrutide value pack 3 × 10mg |
| Amount | 3 × 10 mg |
| Form | Research kit |
| Contents | Three Retatrutide 10mg vials |
| Category | Kits, stacks and value packs |
| Storage | See label |
Every vial in the carton is independent: open one and the remaining two keep their seals intact. Labels repeat the same lot code, which keeps your records simple when a study runs across all three.
Retatrutide value pack price compared with single vials
| Option | Price |
|---|---|
| Retatrutide value pack 3 × 10mg | $469.99 |
Bought one at a time, three single 10mg vials cost a little more than this pack. The difference is small, roughly one fiftieth off each vial, so think of it as a modest loyalty discount on the small size rather than a bulk rate. Laboratories chasing the lowest cost per milligram should compare the single 30mg vial, which holds the same total peptide for noticeably less, or the 2 x 30mg value pack, the cheapest route per milligram in the range. This pack earns its place when three separately sealed portions matter more than the absolute lowest price.
Mixing each Retatrutide 10mg vial: bac water maths
Reconstitution is done vial by vial, and the concentration depends only on the volume of diluent added:
- 1 mL: 10 mg per mL
- 2 mL: 5 mg per mL
- 2.5 mL: 4 mg per mL
- 4 mL: 2.5 mg per mL
Because the three vials are identical, a volume validated on the first carries straight across to the second and third. A 10mL bottle of bacteriostatic water covers all three at 2 mL each with liquid to spare.
Why buy Retatrutide as three separate vials
Once a lyophilised peptide is in solution, the clock starts on its stability. Holding 30 milligrams as three dry 10mg portions means only the vial in use is ever wet, while the other two stay in their most stable state. It also lets a group run parallel experiments from one batch, or pass a sealed vial to a colleague, without transferring solution between containers.
Storing the unopened Retatrutide vials
Sealed vials go straight into a minus 20 °C freezer, kept in the dark. The vial you have mixed moves to the fridge (2 to 8 °C), marked with its mixing date and strength in mg per mL. Leave the spare vials untouched in the freezer until they are needed.
Retatrutide Australia: legal status of the pack
Packing three vials together changes nothing about the compound's position: it is absent from the ARTG, unapproved by the TGA and sold by us as laboratory research material rather than a therapeutic good. Whether any Poisons Standard schedule touches your institution is worth confirming before you buy.
Order the Retatrutide value pack online
Put the pack in your cart alongside diluent or other lab supplies, then tick the checkout declaration that you are 18 or older and ordering for research. Orders go out from Australian stock to metropolitan and regional addresses. Other bundles are grouped under peptide kits, including the Retatrutide starter kit.
References
- LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metabolism. 2022;34(9):1234-1247.
- Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. New England Journal of Medicine. 2023;389(6):514-526.
- Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. The Lancet. 2023;402(10401):529-544.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.